Among the overweight subjects included in the cross-sectional study, the PNPLA3 G/G genotype was significantly associated with an increased ALT value and tended to exhibit a higher prevalence of NAFLD (S2 Table and Table 2). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.